BACKGROUND: Methadone therapy benefits heroin users in both the medical and
psychosocial dimensions. However, both heroin and methadone have cardiac toxicity. Only …

One of the most difficult challenges health care providers encounter is drug selection for
pregnant patients. Drug selection can be complex as efficacy and maternal side effects must …

Illicit opioid use is a growing public health emergency and is associated with adverse
medical and social outcomes. Opioid use in the pregnant population is increasing globally …

Prenatal opioid exposure has recently risen four-fold with limited data on the developmental
effects on neonatal physiology. The objective of this systematic review is to develop an …

Once gestation is beyond 20 weeks, clinicians have to address the impact of illicit
substances on fetal growth, placentation, and the possibility of early delivery. Cannabis …

Objective. Determine whether infants exposed to chronic maternal methadone with
abnormal intrapartum fetal heart rate (FHR) patterns are more likely to require treatment for …

Résumé Objectif Présenter aux professionnels de la santé les données probantes
concernant l'utilisation des opioïdes et la santé des femmes. Les domaines d'intérêt sont la …

Background Buprenorphine, used for opioid use disorder (OUD) treatment during
pregnancy, provides unknown effects on maternal physiological activity. The primary aim of …

Résumé La grossesse chez les femmes usagères de substances psycho-actives (SPA)
interroge souvent les soignants et les patientes elles-mêmes dans une atmosphère de …

Objective: Daily opioid dependence for maternal pain management, methadone
maintenance, or buprenorphine/naloxone therapy is an increasing trend in modern …